D89.832

Cytokine release syndrome, grade 2

Billable code

This code does not map to a risk-adjusting HCC in the loaded models.

Coding notes

Excludes 1 never coded together · Excludes 2 may co-exist

Inherited from D89.83Cytokine release syndrome
Use additional

code for adverse effect, if applicable, to identify immune checkpoint inhibitors and immunostimulant drugs (T45.AX5) code to identify associated manifestations

Code first

underlying cause, such as: complications following infusion, transfusion and therapeutic injection (T80.89-) complications of transplanted organs and tissue (T86.-)

Inherited from D89Oth disorders involving the immune mechanism, NEC
Excludes 1

hyperglobulinemia NOS (R77.1) monoclonal gammopathy (of undetermined significance) (D47.2)

Excludes 2

transplant failure and rejection (T86.-)

Inherited from D80-D89Certain disorders involving the immune mechanism
Includes

defects in the complement system immunodeficiency disorders, except human immunodeficiency virus [HIV] disease sarcoidosis

Excludes 1

autoimmune disease (systemic) NOS (M35.9) functional disorders of polymorphonuclear neutrophils (D71-) human immunodeficiency virus [HIV] disease (B20)

Inherited from chapter 3Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Excludes 2

autoimmune disease (systemic) NOS (M35.9) certain conditions originating in the perinatal period (P00-P96) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) human immunodeficiency virus [HIV] disease (B20) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

Official Guidelines for D89.832

FY 2026 ›

Find D89.832 in the alphabetic index

1 index path leads to this code